Authors
Latest:
Nevada Addresses Costs for Diabetes SuppliesManufacturers file challenge in court resulting in compromise between state government and pharmaceutical companies.
Latest:
Be Mindful of DDIs Between Analgesics and Oral Cancer DrugsAlthough these chemotherapy agents provide convenience and ease, they are subject to hepatic first-pass metabolism and enzymatic drug-drug interactions.
Latest:
Antacid Use During Pregnancy May Lead to Childhood AsthmaUp to 80% of women experience gastro-esophageal reflux disease during pregnancy.
Latest:
Hemophilia and Managed Care: Partnering to Achieve Cost-Effective CareExploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Latest:
Teaching Concentrations Add Value to Colleges of PharmacyDoes your pharmacy institution offer students the opportunity to earn a concentration alongside their PharmD degree?
Latest:
The Pharmaceutical Ecosystem Must Work Together to Provide Sustainable Innovation and Ensure Patient AccessGrowth in the use of specialty drugs demands the evolution of patient care models that leverage the knowledge of all relevant stakeholders.Â
Latest:
Famed Writer Dying of Liver CancerWriter and neurologist Oliver Sacks confirms he has terminal cancer of the liver.
Latest:
Potentially Inappropriate Prescribing of Direct-acting Oral Anticoagulants in the Veterans Health AdministrationThis study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.
Latest:
Oncology Service Lines Prepare Pharmacy for Shift in Cancer Care DeliveryWhat can health systems do to provide a seamless journey during a time of uncertainty?
Latest:
Prevent Diversion During Drug DisposalBuilding a team to support best practices, medication safety, and staff education will reduce risks.
Latest:
Hemophilia Advancements and the Evolution of Patient ManagementThe coordinated-care models and high-touch services provided by specialty pharmacies put them in an ideal position to support patients with hemophilia now and in the future.
Latest:
503B: What Should Pharmacists Know for 2023?When considering outsourcing, pharmacies should use a multistakeholder team to weigh pros and cons.
Latest:
Understanding Predictors of Opioid Abuse: Predictive Model Development and ValidationThis study developed and tested predictive models of opioid abuse using Humana commercial membership data that were subsequently tested in the Truven commercial data set.
Latest:
Irritable Bowel Syndrome: Helping Patients Access Appropriate Treatment in an Era of Investigation and DiscoveryThis Continuing Education activity is supported by an independent educational grant from Allergan Inc. and Prometheus Laboratories, Inc.
Latest:
The Pharmacist’s Role in Maximizing HIV Antiretroviral TherapyThrough ongoing quarterly targeted medication counseling follow-up sessions, the pharmacist may identify ART noncompliance.
Latest:
Real-World Immunoglobulin Dose Adjustments and Impact on Utilization and CostsReal-world dose adjustments occurred in patients with primary immunodeficiency who switched from intravenous immunoglobulin to subcutaneous immunoglobulin 20%, with resulting implications for payers, patients, and plasma collection and supply.
Latest:
ABCs of Avoiding Microvascular Comorbidities of DiabetesDr. Santamarina is an assistant professor of pharmacy practice at Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy, West Palm Beach, Fla.
Latest:
Ensuring Health Equity in Vaccination Access: How Pharmacies Can Work With Community OrganizationsCommunity pharmacies and organizations can collaborate to tailor strategies and interventions and address the challenges and specific needs of the community.
Latest:
Use of Multiple Sclerosis Disease-Modifying Therapies During COVID-19 PandemicIn the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.
Latest:
Comparing Direct Medical Costs of OnabotulinumtoxinA With Other Common Overactive Bladder InterventionsThis cost analysis demonstrated that onabotulinumtoxinA is one of the least-costly treatment options for inadequately managed overactive bladder syndrome.
Latest:
Metastatic Breast Cancer UpdatesIncremental gains in survival and new targeted agents in the pipeline offer promise.
